Monthly Archives: November 2021

Health

Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge, Upcoming Webinar Hosted by Xtalks

Leave a comment


The goal of this webinar is to provide case studies for the two typically used assay formats for measuring total antibodies (direct and bridging) and discuss the challenges and rationales for using each of them in the AAV immunogenicity space.


TORONTO (PRWEB)

Assessing humoral immunogenicity is an interesting challenge for adeno-associated virus (AAV)-based gene therapies. While most people are concerned about how to deal with pre-existing antibodies and their impact on cutpoints — such as using total antibody or neutralizing antibodies for inclusion/exclusion, including/excluding based on these results and a number of other concerns — often times just coming up with the right assay format for measuring these antibodies is overlooked.

The goal of this webinar is to provide case studies for the two typically used assay formats for measuring total antibodies (direct and bridging) and discuss the challenges and rationales for using each of them in the AAV immunogenicity space. The case studies will be followed by a panel discussion with an expert scientific team to take questions and discuss other possibilities for assay format selection.

Register for this webinar to learn about the rationale behind choosing an assay format for total antibody (TAb) assays for AAV-based gene therapies, including the pros and cons of each format.

Join expert speakers from BioAgilytix, Jim McNally, PhD, Chief Scientific Officer, who will be moderating the event; Jay Stringer, PhD, Manager I; Luke Armstrong, PhD, Manager II; Todd Lester, Associate Director; and Xiaoxi Yang, PhD, Manager I, for the live webinar on Monday, December 6, 2021 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health

DuPont to Highlight Medical Device Partnerships and Opportunities during MEDICA 2021

Leave a comment


News Image


WILMINGTON, Del. (PRWEB)

DuPont (NYSE:DD) today announced that it will highlight opportunities for collaborative medical device partnership with its DuPont™ Liveo™ Healthcare Solutions and DuPont™ Intexar™ brands at MEDICA 2021, November 15 to 18 in Duesseldorf, Germany.

Technical representatives will be on the show floor at booth D21 in hall 12 to discuss the company’s ongoing partnership with TNO Holst Centre and Pronat Medical who have designed and produced the Nighthawk™ wearable adhesive patch. The concept patch combines DuPont material solutions for the medical device market, through Intexar™ stretchable materials, including thermoplastic polyurethane (TPU) films and stretchable conductive inks, with DuPont™ Liveo™ silicone skin adhesives, suitable for attaching wearable devices to the body, and Liveo™ biosensing technology. The combination of these innovative materials in a connected wearable medical patch offers conformability, biocompatibility, breathability and patient comfort.

Innovative technologies for wearable medical devices are highly valued because of the huge market growth potential for such devices and the need to improve their performance to positively impact patient comfort and compliance. DuPont offers a collaborative ecosystem for designers and manufacturers to work with the company’s medical device experts and innovative material technologies to create next-generation wearable devices.

Attendees also can hear from DuPont Healthcare TS&D/R&D medical devices expert Alexis Bobenrieth, Ph.D., during the MEDICA DISRUPT “Diagnostics and health monitoring” session scheduled from 12:15 to 2:30 p.m. CET on Nov. 17.

In his talk, “Partnering to enable next-generation smart wearable patches,” Bobenrieth will describe how DuPont worked with technology partners to develop a wearable smart patch that is ready to be commercialized; he also will explain how the DuPont Toolbox can help enable next-generation wearable design that improve device performance, wearability and patient comfort throughout the lifecycle of the wearer.

MEDICA 2021 participants can attend the session in person in Hall 12 or view it virtually. Visit the MEDICA website at medica-tradefair.com for more information.

About DuPont™ Liveo™ Healthcare Solutions

DuPont™ Liveo™ is a globally recognized leader in technology for a broad range of innovations in medical devices, biopharmaceutical processing and pharmaceutical solutions. DuPont high-performance materials help create safer healthcare environments and protect the health of patients and healthcare providers worldwide. We help enable smarter healthcare and positive patient outcomes. More information can be found at liveo.dupont.com.

About DuPont Electronics & Industrial

DuPont Electronics & Industrial is a global supplier of new technologies and performance materials serving the semiconductor, circuit board, display, digital and flexographic printing, healthcare, aerospace, industrial, and transportation industries. From advanced technology centers worldwide, teams of talented research scientists and application experts work closely with customers, providing solutions, products and technical service to enable next-generation technologies.

About DuPont Microcircuit and Components Materials

DuPont Microcircuit and Components Materials (MCM) is a leading global supplier of printable, stretchable, and moldable functional inks and pastes. With over 50 years of developing products for our customers, we are relied upon every day in automotive electronics, telecommunications systems, consumer electronics, aerospace, satellite communications, military, industrial, bio, and healthcare applications. We are committed to innovation through seamless collaboration with customers, providing cutting-edge products and solutions to address critical challenges of today and tomorrow. To learn more about the MCM business, please visit http://mcm.dupont.com.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

# # #

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. Nighthawk™ is a trademark of TNO Holst Centre.

11/15/21

Share article on social media or email:

Health

John Brooks Recovery Center receives Best of the Press 2021 Silver Award

Leave a comment


John Brooks Recovery Center receives Best of the Press 2021 Silver Award for Best Drug/Alcohol Recovery Program.

“We are honored to receive the Best of the Press 2021 Silver Award,” said Michael Santillo, CEO of JBRC. “Through this wonderful recognition, we promise to continue to spread awareness and provide recovery, hope and healing to help even more people overcome substance use disorders.”


MAYS LANDING, N.J. (PRWEB)

John Brooks Recovery Center (JBRC) receives Silver Award for the Best Drug/Alcohol Recovery Program in Press of Atlantic City’s 2021 Best of the Press Readers’ Choice Awards.

“We are honored to receive the Best of the Press 2021 Silver Award,” said Michael Santillo, CEO of JBRC. “Through this wonderful recognition, we promise to continue to spread awareness and provide recovery, hope and healing to help even more people overcome substance use disorders.”

The nonprofit offers a Main Outpatient Recovery Center in Pleasantville, an Outpatient Center in Atlantic City and a Residential Treatment Facility in Mays Landing. “Our goal is to provide a full continuum of care for individuals suffering from substance use disorders regardless of financial circumstance or socio-economic background,” said Santillo.

If you or someone you know is struggling with a substance use disorder, please call JBRC today. For Residential Programs – Residential Detox/Withdrawal Management, Short-term Residential or Long-term Residential, please call 609-345-0110. For Outpatient Programs – Opioid Treatment Program, Intensive Outpatient Program or Standard Outpatient Program, please call 609-345-2020, extension 6182, 6180 or 6179.

About John Brooks Recovery Center

Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include: Residential, Outpatient, Medication-assisted Recovery, Detox and Inmate Re-entry. To learn more, visit jbrcnj.org or visit them on Facebook @JohnBrooksRecoveryCenter.

About All Roads Recovery Community Center

All Roads Recovery Community Center, the community-based recovery arm of JBRC, helps anyone struggling with addiction navigate their next steps on the journey to recovery. All Roads currently offers a wide variety of Recovery Groups, as well as one-on-one coaching with Certified Peer Recovery Specialists (CPRS). To learn more, visit allroadsrecovery.org, call 609-457-1080 or visit them on Facebook @AllRoadsRCC.

Share article on social media or email:

Health

Evolve Recovery Center is proud to be a collection location for Toys…

Leave a comment


Evolve Recovery Center, a residential drug and alcohol treatment program is collecting unwrapped toys for The Marines Toys for Tots program at each of its 3 locations nationwide. Stop by and drop off…

(PRWeb November 15, 2021)

Read the full story at https://www.prweb.com/releases/evolve_recovery_center_is_proud_to_be_a_collection_location_for_toys_for_tots_this_2021_holiday_season/prweb18331225.htm

Health

Nierman Practice Management Launches New Cloud Platform DentalWriter Plus+ for Medical Billing in Dentistry

Leave a comment


DentalWriter Plus+ streamlines the dental office workflow and medical reimbursement for dental sleep medicine, TMJ disorders, and oral surgeries.

DentalWriter Plus+ Cloud Dental Platform for Medical Billing and Dental Sleep Medicine

We prioritized the optimization of user experience to make medical billing in dentistry and dental sleep medicine easy and rewarding.


JUPITER, Fla. (PRWEB)

Nierman Practice Management (NPM), the leading company for helping dental practices implement medical billing and sleep apnea treatment, announced today the launch of DentalWriter Plus+.

DentalWriter Plus+ is a web-based cloud EMR software designed exclusively for dental practices treating sleep apnea, TMJ disorder, and oral surgeries to streamline the medical billing workflow needed for effective practice growth.

“We know how important efficiency is for dental practices billing medical insurance for sleep apnea, TMJ, CBCT, and oral surgery services. We prioritized the optimization of user experience to make medical billing in dentistry and dental sleep medicine easy and rewarding,” says Jon Nierman, President of Nierman Practice Management.

DentalWriter Plus+ features an intuitive workflow and intelligent automation that documents cases in the medical model, facilitating implementation of sleep apnea oral appliance therapy and other dental services that often have coverage through medical insurance plans.

It is estimated that over 22 million Americans suffer from obstructive sleep apnea (OSA), with the vast majority left untreated. Dentists play a key role in providing needed care through oral appliance therapy. In 2017, the American Dental Association (ADA) adopted a policy on dentistry’s role in treating sleep-breathing disorders (SBD) including OSA. It highlights that dentists should be screening for SBD and are the only healthcare providers with the expertise to fabricate oral appliances.

The biggest challenge with dentists implementing oral appliance therapy is medical billing. Dental practice management systems are not designed to meet the requirements needed for efficient medical reimbursement. Rose Nierman, CEO of NPM identified this problem over 33 years ago and invented the first software that expedited documentation and medical reimbursement in the dental office.

“We have a long history of innovation in dental solutions for medical billing,” says Rose. “DentalWriter Plus+ leverages next-generation technology, is accessible from any device with an internet connection, and automates the essential tasks for dental sleep medicine, TMD, and oral surgeries, including documentation, medical billing, and physician referral building.”

One of the most highly-anticipated features is the seamless integration with Nierman Medical Billing Service.

“Over the years we have recognized the need for better communication between dental practices and medical insurance carriers. The DentalWriter Plus+ integration with Nierman Medical Billing Concierge Service creates an air-tight end-to-end solution that eliminates the need for fax, email, and phone. Users can check real-time claims and pre-authorization status and engage in instant chat with their concierge. This is a major time-saving tool for dental practices,” says Courtney Snow, Vice President of NPM.

DentalWriter Plus+ enables users to get up and running right away through an intuitive UI and the proprietary DentalWriter Navigator; a concise interactive checklist that ensures accurate protocols from initiation to completion.

Additionally, the cloud platform facilitates physician referral-building through individualized narrative report communication. Internal communications with other health professionals are essential for dentists treating medically necessary conditions, making DentalWriter Plus+ a powerful tool for building relationships and gaining new patients.

DentalWriter Plus+ officially launched at the 2021 Current Trends in Dental Sleep Medicine Symposium. Dental practices can learn more and get started with DentalWriter Plus+ at https://niermanpm.com/dental-sleep-billing-software

Share article on social media or email:

Health

Potential Impacts on Consumers, the Environment, and Agricultural Producers”

Leave a comment


News Image


AMES, Iowa (PRWEB)

The Council for Agricultural Science and Technology’s (CAST) new paper, ”Gains Foregone by Going GMO Free: Potential Impacts on Consumers, the Environment, and Agricultural Producers” is now available for free download. The objective is to communicate the benefits of GMOs and the potential cost to society if the technology were removed from the marketplace.

This commentary looks at the benefits of GMOs to consumers, the environment, and crop and livestock producers, and it discusses realized and potential costs of restricting GMO applications. The research cited in this paper shows that GMOs use less land, energy, and chemicals, and the carbon footprint of agriculture would certainly increase without GMOs. The authors examine gene editing technologies and how to regulate agricultural innovation. Dr. McFadden, the chair of this paper, pointed out there is evidence in the U.S. that consumers are supportive of GE applications to reduce the prevalence of agricultural diseases like citrus greening.

Within the span of 25 years since their first widespread commercial adoption, GMO crops have transformed production systems in the places where the technology has been used. Without continued innovation and adoption of biotechnology like GMOs, the future of reducing food insecurity becomes an increasingly remote and unlikely scenario.

The Commentary, Gains Foregone by Going GMO Free: Potential Impacts on Consumers, the Environment, and Agricultural Producers, is available to download on CAST’s website. The webinar will take place at Noon Central on Tuesday, Nov. 16. Dr. Brandon McFadden and a panel of the paper’s authors will share highlights of the publication, followed by a Q&A session. Registration for the free webinar can be made here.

Taskforce Members and Contributors

  • Dr. Brandon McFadden, Chair, University of Delaware

  • Dr. Alison Van Eenennaam, University of California, Davis

  • Dr. Ellen Goddard, University of Alberta

  • Dr. Jayson Lusk, Purdue University

  • Dr. Jill McCluskey, Washington State University

  • Dr. Stuart J. Smyth, University of Saskatchewan

  • Dr. Farzad Taheripour, Purdue University

  • Dr. Wallace E. Tyner, Purdue University

About CAST

CAST is an international consortium of scientific and professional societies, universities, companies, nonprofits, libraries, and individuals. CAST convenes and coordinates networks of experts to assemble, interpret, and communicate credible, unbiased, science-based information to policymakers, the media, the private sector, and the public.

Share article on social media or email:

Health

Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Management of Bradyarrhythmia Presented at the American Heart Association’s Scientific Sessions 2021

Leave a comment


electrophysiology cardiology temporary cardiac pacing

The Tempo® Temporary Pacing Lead (BioTrace Medical Inc, Menlo Park CA)

“The Tempo Lead is very useful for the support of temporary bradyarrhythmias that require reliable early- or medium-term temporary pacing as a bridge to resolution or permanent pacemaker implantation,” said Anish K. Amin, MD, cardiac electrophysiologist at OhioHealth Riverside Methodist Hospital.


MENLO PARK, Calif. (PRWEB)

BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo® Temporary Pacing Lead was featured in a clinical study presented at the American Heart Association’s Scientific Sessions 2021, held November 13-15 in Orlando, Florida.

The study, titled “A Retrospective Analysis of a Single-Center Experience with the Tempo Temporary Pacing Lead in Management of Bradyarrhythmia and Other Cardiac Electrophysiology Procedures”, analyzed a series of twelve consecutive patients who underwent Tempo Lead placement for temporary pacing at OhioHealth Riverside Methodist Hospital in Columbus, Ohio.

Twelve consecutive patients (83% male, mean age 71.3 ± 10.1 years) who underwent Tempo Lead placement for temporary pacing were retrospectively reviewed (75% symptomatic bradyarrhythmia, 25% other indications including permanent lead malfunction, permanent pacemaker infection, and complete heart block.) The Tempo Lead was successfully positioned and fixed in the right ventricle in all twelve cases with no perforations, pericardial effusions, or device-related arrhythmias. Access was femoral in eight patients (67%) and jugular in three patients (25%), with one access point not indicated.

Procedural mean pace capture threshold (PCT) was 0.96 ± 0.74 mA (n=10). Mean lead indwelling duration was 53.5 hours with a range of 20.9 hours to 5.9 days (n= 11). Three patients were ambulatory (at least bed-to-chair) with the Tempo Lead in place without complications and with maintenance of thresholds <1mA.

The Tempo Lead’s novel design – featuring retractable stabilizer loops and a soft tip – minimizes the risks of dislodgment and perforation, ensures stability during rapid pacing, and facilitates patient ambulation in recovery.

“The Tempo Lead is very useful for the support of temporary bradyarrhythmias that require reliable early- or medium-term temporary pacing as a bridge to resolution or permanent pacemaker implantation,” said Anish K. Amin, MD, cardiac electrophysiologist at OhioHealth Riverside Methodist Hospital. “Its unique design provides temporary pacing without the risk of dislodgment, loss of pace capture, or perforation inherent in conventional temporary leads.”

With U.S. FDA clearance and CE certification, the Tempo Lead is the only active fixation temporary pacing lead available in the world. The Tempo Lead has been used in more than 12,000 U.S. procedures with an excellent safety and performance profile, as demonstrated by reported “real-world” 0.04% cardiac perforation rate and a 0.11% intermittent/loss of pace capture rate.1 (Conventional temporary pacing leads exhibit cardiac perforation rates ranging from 0.6% to 4.0%, and dislodgment/loss of pace capture rates between 10% and 37%.2)

About BioTrace Medical

BioTrace Medical, Inc., a private venture-backed company based in Menlo Park, California, is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs. For more information, visit http://www.biotracemedical.com.

(1) Company data on file as of October 2021.

(2) Metkus, et al. Chest. 2019; Lopez, et al. Rev Esp Cardiol. 2004; Betts, Postgrad Med J. 2003; Jowett, et al. Postgrad Med J. 1989; Austin, et al. Am J Cardiol. 1982; Gammage, Heart 2000; Lumia et al. Chest 1973

APM042-01.A

Share article on social media or email:

Health: Mental Health

Media & Music Industry Veteran, Now Mental Health Practitioner, Marvin Houston, Offers Healing for the Mind, Body, and Soul of the Entertainment Industry

Leave a comment


Marvin Houston, Entertainment Health & Wellness Coach and Founder of Houston & Associates, LLC

Marvin Houston, Entertainment Health & Wellness Coach and Founder of Houston & Associates, LLC

We now have a front-row seat to many talented professionals battle with addiction, anxiety, to difficulty managing their anger which sometimes results in violence and abuse to themselves or others


LOS ANGELES (PRWEB)

Media & music industry veteran Marvin Houston marks January 1, 2022, as the launch date for his latest business and service venture as an Entertainment Health & Wellness Coach under his newly minted Houston & Associates, LLC banner.

The New York City-based Houston & Associates is an exclusive support agency designed to provide coaching, holistic care, education, and resources to individuals within the entertainment industry. The company will serve as a resource to record labels and entertainment companies, support entertainment executives, creative producers, and talent nationally.

Clients can obtain the help and support they need with various coaching services – career burnout, relief from depression and anxiety, conflict resolution, drug and alcohol abuse, identity crisis/exploration, and more.

“From social media to the news, we’ve witnessed how fame or the ongoing pressure from fans and publicity contributed to some of our brightest stars dying by suicide. We now have a front-row seat to many talented professionals battle with addiction, anxiety, to difficulty managing their anger which sometimes results in violence and abuse to themselves or others,” says Houston.

Addressing these very public mental health issues within the entertainment industry, Houston has developed the MENTAL HEALTH 101 WORKSHOP for ENTERTAINMENT Professionals. The educational seminar is uniquely designed for individuals in the entertainment industry that teaches individuals how to identify, understand, and respond to signs of mental illnesses and addictions. It also provides relevant strategies and ways to help someone developing or experiencing a mental health or substance abuse crisis.

Houston brings more than 20 years of entertainment and mental health experience into his new role. As a graduate of Full Sail University with a bachelor’s degree in Music Business, he also possesses a master’s degree in Clinical Mental Health Counseling from Capella University. Houston is also a Kemetic Reiki Practitioner, Certified Anger Management Specialist, and Certified Sound Therapy Practitioner.

For more information about contacting or booking a session with the Entertainment Health & Wellness Coach, contact him at MarvinHouston.com. In response to the COVID-19 pandemic, sessions are currently virtual, and there are limited in-person sessions available in Houston’s New York City or Atlanta offices.

Share article on social media or email:

Health

Einstein Healthcare Expands Partnership With Within Health To Reduce Admin Burden And Improve Patient Retention

Leave a comment



PHILADELPHIA (PRWEB)

Einstein Healthcare Network, an innovative academic health system in Pennsylvania, announced it is expanding its partnership with Within Health to its entire radiology patient population. Within Health is the fastest growing care navigation automation company, using advanced technology to identify, engage and coordinate care for patients with unresolved follow-up recommendations. This partnership will enable Einstein Healthcare Network’s radiologists to focus on patient care, while reducing the administrative burden of managing follow-up scheduling. Einstein Healthcare Network services the Greater Philadelphia region conducting more than 400,000 imaging exams annually.

“It’s important to Einstein Healthcare Network to remain at the forefront of implementing groundbreaking technology to provide optimal care to our patients and the ideal environment for our radiologists and care teams to do their best work,” said Dr. Micah Cohen, Associate Chair of Departmental Quality and Safety of Radiology at Einstein Healthcare Network. “We are encouraged with our preliminary results which demonstrated improvement in follow-up adherence since implementing Within Health and how it has improved our patients’ lives and care team workflows. Within Health is a forward thinking partner that is innovative and prioritizes developing long-term successful partnerships.”

Within Health creates operational efficiencies by automating the identification, tracking, and engagement of patients at-risk of a delayed or missed follow-up care. Within Health utilizes natural language processing, AI, and engagement algorithms to accurately identify recommendations and engage stakeholders to create positive behavior change. In addition, Within Health reduces administrative burden by automating workflows associated with follow-up. All of this is done without impacting the physician workflow.

“After our pilot study showed significant improvement in follow-up adherence for at-risk patients, we are planning to expand our project to include all radiology patients. It has been great to collaborate with Within Health as they are responsive and prioritize feedback,” said Dr. Ryan Lee, Chair of Radiology at Einstein Healthcare Network.

“Our partnership with Einstein Healthcare Network is a prime example of how forward thinking and innovative health systems are adopting AI and automation solutions to create better health outcomes, reduce administrative burden and burnout and provide a better experience for patients.” said Adam Kirell, co-founder and CEO of Within Health. “We’re excited to expand our partnership with the incredible team at Einstein Healthcare Network and look forward to continuing to grow the relationship into the future.”

Einstein Healthcare Network will be presenting the detailed results from the successful pilot program at the RSNA conference at McCormick Place in Chicago on Monday November 29th at 12:30pm.

About Einstein Healthcare Network:

Einstein Healthcare Network is a health care system with approximately 1,000 beds and more than 8,700 employees serving the communities of Philadelphia and Montgomery County, Pa. The Network is made up of three acute care hospitals including Einstein Medical Center Philadelphia, the largest independent academic medical center in the Philadelphia region training over 3,500 health professional students each year with more than 450 residents and fellows in over 35 accredited programs; Einstein Medical Center Elkins Park; and Einstein Medical Center Montgomery. The Network also includes Moss Rehab, consistently ranked by U.S. News &amp; World Report as a top rehabilitation hospital in the nation; Willowcrest, named by U.S. News &amp; World Report as one of the best nursing homes for short-term rehabilitation care in Philadelphia; outpatient care centers; and a network of more than 900 primary care physicians and specialists throughout the region. For more information, visit http://www.einstein.edu or call 1-800-EINSTEIN.

About Within Health:

Within Health aims to improve patient retention and reduce patient leakage, providing health systems and practices with improved revenue, reduced liability, and enabling higher quality care for patients.

Co-founded by healthcare technology, data analytics, and digital communication experts, Within Health is working with some of the largest and most innovative radiology practices and health systems in the US and expanding quickly. Within Health is based in Brooklyn, NY and backed by Antler and Brand New Matter Ventures.

Learn more about Within Health at http://www.seewithin.co or on Twitter @seewithinhealth.

Share article on social media or email:

Health

AONN+ Foundation For Learning Certification Receives Nation’s Highest Nursing Recognition

Leave a comment



CRANBURY, N.J. (PRWEB)

The AONN+ Foundation for Learning (AONN+ FFL) announced that its oncology navigator certifications have received the prestigious Magnet Recognition by the American Nurses Credentialing Center (ANCC).

The ANCC’s Magnet Recognition Program distinguishes organizations that meet rigorous standards and is considered the highest recognition for nursing excellence. U.S. News & World Report’s annual showcase of “America’s Best Hospitals” includes Magnet recognition in its ranking criteria for the quality of inpatient care.

Oncology Nurse Navigator-Certified Generalist (ONN-CG) and Oncology Patient Navigator-Certified Generalist (OPN-CG), the 2 AONN+ FFL certifications, were created in response to increasing demands for a specific type of certification that distinguishes the knowledge, skills, and role of oncology navigators from that of other types of nursing certifications.

The purpose of these 2 certifications is to ensure that clinical nurse and patient navigators have the knowledge to competently demonstrate effective navigation services across the cancer care continuum within their scope of practice.

The ONN-CG and OPN-CG certifications are accredited through ANSI National Accreditation Board (ANAB), a wholly owned subsidiary of the American National Standards Institute (ANSI).

American Nurses Credentialing Center (ANCC) is a subsidiary of the American Nurses Association. ANCC accredits healthcare organizations that provide and approve continuing nursing education and accredits transition to practice programs and prepares nurses for new practice roles.

More information about AONN+ FFL certifications can be found at https://aonnffl.org.

About AONN+ Foundation for Learning, Inc.(http://www.aonnffl.org)

AONN+ Foundation for Learning, Inc. (AONN+ FFL) is a specialty organization created in 2010 through affiliation with The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+). AONN+ FFL is a separate legal entity that oversees the ONN-CG and OPN-CG certification exams and manages all activities related to ANAB accreditation and oncology navigator certification.

About the Academy of Oncology Nurse & Patient Navigators, Inc. (http://www.aonnonline.org)

The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+), is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. The organization, which has more than 8900 members, was founded in 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services in order to better manage the complexities of the cancer treatment process.

About The Lynx Group (http://www.thelynxgroup.com)

The Lynx Group (TLG) is a premier medical communications and education company acutely focused on oncology and rare disease states. TLG specializes in market access to and with advanced practice providers, patients, and their caregivers. With more than 100 years of combined senior leadership experience, TLG continually creates award-winning medical education and cultivates strong relationships within proprietary brands serving patients and their caregivers, physicians, payers, nurses, pharmacists, navigators, and practice managers.

TLG has broad and deep experience in crafting custom, award-winning solutions for life science and biotech companies. Currently, TLG partners with more than 50 of the top pharma and biotech companies globally. TLG proudly serves as co-founder and association management company of the Academy of Oncology Nurse & Patient Navigators (AONN+) and the Association for Value-Based Cancer Care (AVBCC).

Carol Bustos, (732) 992-1893

cbustos@the-lynx-group.com

Share article on social media or email: